|
CASEBIA
Filed on: 6/23/2016
|
Gene therapy products, namely, therapeutics for the treatment of liver, hepatological, cardiovascular, central nervous system, endocrine, gastrointestinal, immunological, dermatological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological...
read more...
|
ABANDONED - NO STATEMENT OF USE FILED
3/16/2020
|
|
|
CASEBIA
Filed on: 6/23/2016
|
Gene therapy products, namely, therapeutics for the treatment of liver, hepatological, cardiovascular, central nervous system, endocrine, gastrointestinal, immunological, dermatological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological...
read more...
|
ABANDONED - NO STATEMENT OF USE FILED
3/9/2020
|
|
|
CASEBIA
Filed on: 6/23/2016
|
Gene therapy products, namely, therapeutics for the treatment of liver, hepatological, cardiovascular, central nervous system, endocrine, gastrointestinal, immunological, dermatological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological...
read more...
|
ABANDONED - NO STATEMENT OF USE FILED
3/16/2020
|
|
|
CASEBIA
Filed on: 6/23/2016
|
Research and development of human therapeutics using gene editing; pharmaceutical research and development services
read more...
|
CONTINUED USE NOT FILED WITHIN GRACE PERIOD, UN-REVIVABLE
4/5/2024
|
|
|
CASEBIA
Filed on: 6/23/2016
|
Research and development of human therapeutics using gene editing; pharmaceutical research and development services
read more...
|
CONTINUED USE NOT FILED WITHIN GRACE PERIOD, UN-REVIVABLE
4/5/2024
|
|